1. Readmission following both cardiac and non-cardiac acute dyspnoea is associated with a striking risk of death
- Author
-
Nikola Kozhuharov, Aušra Kavoliūnienė, Loreta Bagdonaitė, Julia Dinort, Eglė Palevičiūtė, Kamilė Čerlinskaitė, Dovilė Vaičiulienė, Irina Alitoit‐Marrote, Vytautas Juknevičius, Eleni Michou, Raphaël Cinotti, Christian Mueller, Danielle Menosi Gualandro, Šarūnas Damalakas, Alexandre Mebazaa, Kęstutis Stašaitis, Desiree Wussler, Mindaugas Balčiūnas, Jelena Čelutkienė, Justina Motiejūnaitė, Denis Kablučko, Aleksandras Laucevičius, Michael A. Matthay, Ieva Jonauskienė, Etienne Gayat, and Audrys Kukulskis
- Subjects
medicine.medical_specialty ,acute dyspnoea ,acute heart failure ,emergency department ,mortality ,readmission ,vulnerable phase ,030204 cardiovascular system & hematology ,Patient Readmission ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Original Research Articles ,Internal medicine ,medicine ,Humans ,Diseases of the circulatory (Cardiovascular) system ,In patient ,Original Research Article ,030212 general & internal medicine ,Mortality ,Acute dyspnoea ,Heart Failure ,business.industry ,Proportional hazards model ,Emergency department ,Hazard ratio ,Acute heart failure ,medicine.disease ,Confidence interval ,Hospitalization ,Dyspnea ,Heart failure ,RC666-701 ,Vulnerable phase ,Etiology ,Risk of death ,Cardiology and Cardiovascular Medicine ,business ,Readmission - Abstract
Aims Readmission and mortality are the most common and often combined endpoints in acute heart failure (AHF) trials, but an association between these two outcomes is poorly investigated. The aim of this study was to determine whether unplanned readmission is associated with a greater subsequent risk of death in patients with acute dyspnoea due to cardiac and non‐cardiac causes. Methods and results Derivation cohort (1371 patients from the LEDA study) and validation cohort (1986 patients from the BASEL V study) included acute dyspnoea patients admitted to the emergency department. Cox regression analysis was used to determine the association of 6 month readmission and the risk of 1 year all‐cause mortality in AHF and non‐AHF patients and those readmitted due to cardiovascular and non‐cardiovascular causes. In the derivation cohort, 666 (49%) of patients were readmitted at 6 months and 282 (21%) died within 1 year. Six month readmission was associated with an increased 1 year mortality risk in both the derivation cohort [adjusted hazard ratio (aHR) 3.0 (95% confidence interval, CI 2.2–4.0), P
- Published
- 2021